It plays an active role in the planning, execution and reporting of the phase I-III studies carried out in order to obtain bioavailability/ bioequivalence studies and pharmacokinetic (PK)/ pharmacodynamic (PD) data that support the research and development studies of the pharmaceutical industry.
Novagenix on-site conducted clinical trials first year of work organizations a single center in Turkey, which and processes in various foreign authorities (Germany, South Africa, Austria, Spain) also audited, the "Erciyes University Medical Faculty Hakan Çetinsaya HR Center-Kayseri" and began to be carried out; With the opening of "FARMAGEN Clinical Research Center-Gaziantep" in 2009, studies continue to be conducted with both clinics.
